Together, the findings reveal a novel link between metabolic dysregulation and cell fate regulation at the chromatin level in fibrosis, mediated by the O‐GlcNAc‐JUNB axis, suggesting avenues for the development of new therapeutic strategies in IPF. This evidence concerns the gene JUNB and idiopathic pulmonary fibrosis.